PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences

Rhea-AI Summary

PLx Pharma Inc. (NASDAQ: PLXP) announced virtual presentations at two healthcare conferences. The JMP Securities Life Sciences Conference will take place on June 16, 2021, at 12:30 PM ET, and the Raymond James Human Health Innovation Conference on June 21, 2021, at 2:40 PM ET. Key executives Natasha Giordano and Rita O’Connor will present the company’s innovative drug delivery platform, PLxGuard™, and its lead product, VAZALORE™, an FDA-approved liquid-filled aspirin capsule. Webcast links for both events are provided for public access.

SPARTA, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products, with its lead products VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”), announced today that Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer, will present virtually at two upcoming healthcare conferences as follows:

The JMP Securities Life Sciences Conference:
Date:	Wednesday, June 16, 2021
Time:	12:30PM Eastern Time
Webcast Link:	https://wsw.com/webcast/jmp49/plxp/1710800
The Raymond James Human Health Innovation Conference 2021:
Date:	Monday, June 21, 2021
Time:	2:40PM Eastern Time
Webcast Link:	https://kvgo.com/rj-health/plx-pharma-inc-june-2021

The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.plxpharma.com, under the ‘Investors Relations’ Section.

About VAZALORE

VAZALORE is an FDA-approved liquid-filled aspirin capsule that provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable and predictable platelet inhibition as compared to enteric-coated aspirin. It also reduces the risk of stomach erosions and ulcers, as compared to immediate-release aspirin, common in an acute setting.

About PLx Pharma Inc. 

PLx Pharma Inc. is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs.

To learn more about PLx Pharma Inc. and its pipeline, please visit www.plxpharma.com.

Contact
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

FAQ

When is PLx Pharma presenting at the JMP Securities Life Sciences Conference?

PLx Pharma will present at the JMP Securities Life Sciences Conference on June 16, 2021, at 12:30 PM Eastern Time.

When is PLx Pharma presenting at the Raymond James Human Health Innovation Conference?

PLx Pharma's presentation at the Raymond James Human Health Innovation Conference is scheduled for June 21, 2021, at 2:40 PM Eastern Time.

What is VAZALORE from PLx Pharma?

VAZALORE is an FDA-approved liquid-filled aspirin capsule that provides fast and reliable platelet inhibition, reducing the risk of stomach erosions and ulcers compared to immediate-release aspirin.

Who will represent PLx Pharma in the upcoming conferences?

Natasha Giordano, President and CEO, and Rita O’Connor, CFO, will represent PLx Pharma at the upcoming healthcare conferences.

Where can I watch the PLx Pharma conference presentations?

The presentations can be watched live through the company's website and will be archived for 30 days after the events.